Page 303 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 303
YI P1050 ASSOCIATION OF FAMILY HISTORY OF METABOLIC ePOSTERS
YI P1051 TRAITS WITH AGE AT DIAGNOSIS AND SEVERITY OF
YI P1052 NON ALCOHOLIC STEATOHEPATITIS (NASH) RELATED
CIRRHOSIS
YI P1053 Ajeet S. Bhadoria*, Chandan K. Kedarisetty, Varsha Shasthry,
YI P1054 Manoj K. Sharma, Jaya Benjamin, Guresh Kumar, Ankit Bhardwaj,
YI P1055 S Muralikrishna Shasthry, Tanmay Vyas, Shivkumar Sarin, India
ALGINATE ENRICHED BREAD ATTENUATE CIRCULATING
LIPIDS AND NON-ALCOHOLIC FATTY LIVER DISEASE
David Houghton*, Peter Chater, Matthew Wilcox, Iain Brownlee,
Michael I. Trenell, Chris Seal, Jeffrey Pearson, The United Kingdom
AN IMBALANCE BETWEEN TH17 AND TREG KEY TO
PATHOGENESIS OF NON-ALCOHOLIC FATTY LIVER
DISEASE IN MORBIDLY OBESE PATIENTS
Paula Iruzubieta, Maria Teresa Arias-Loste*, Agustín Domínguez,
Antonio López-Useros, Carolina Santa Cruz, Ángel Estébanez,
David San Segundo, David Ramos, Ainara Azueta, Susana Llerena,
Carmen Alonso, Joaquin Cabezas, Marcos López Hoyos, Javier Crespo,
Spain
PREVALENCE OF PATATIN-LIKE PHOSPHOLIPASE DOMAIN
CONTAINING 3 (PNPLA3) RS738409 C/G POLYMORPHISM IN
PATIENTS WITH BONA-FIDE POST-NASH CIRRHOSIS
Paolo Gallo, Umberto Vespasiani Gentilucci, Giovanni Galati,
Antonio De Vincentis*, Livia Piccioni, Elisabetta Riva, Antonio Picardi,
Italy
LIVER ENZYMES, ADIPONECTIN AND VITAMIN D LEVELS
AS PREDICTORS OF DIABETES – DATA FROM THE HEINZ
NIXDORF RECALL STUDY
Julia Kälsch*, Lars P. Bechmann, Dominik Heider, Paul Manka,
Hagen Kälsch, Jan-Peter Sowa, Susanne Moebus, Uta Slomiany,
Karl-Heinz Jöckel, Raimund Erbel, Guido Gerken, Ali Canbay, Germany
THE MACROPHAGE ACTIVATION MARKER SOLUBLE
CD163 IS INDEPENDENTLY ASSOCIATED WITH THE
SEVERITY OF NAFLD IN MORBID OBESITY AND REDUCED
BY BARIATRIC SURGERY
Konstantin Kazankov*, Joan Tordjman, Holger J. Møller,
Hendrik Vilstrup, Christine Poitou, Pierre Bedossa, Jean-Luc Bouillot,
Karine Clement, Henning Grønbæk, Denmark
Vienna, Austria • April 22–26, 2015 303
YI P1051 TRAITS WITH AGE AT DIAGNOSIS AND SEVERITY OF
YI P1052 NON ALCOHOLIC STEATOHEPATITIS (NASH) RELATED
CIRRHOSIS
YI P1053 Ajeet S. Bhadoria*, Chandan K. Kedarisetty, Varsha Shasthry,
YI P1054 Manoj K. Sharma, Jaya Benjamin, Guresh Kumar, Ankit Bhardwaj,
YI P1055 S Muralikrishna Shasthry, Tanmay Vyas, Shivkumar Sarin, India
ALGINATE ENRICHED BREAD ATTENUATE CIRCULATING
LIPIDS AND NON-ALCOHOLIC FATTY LIVER DISEASE
David Houghton*, Peter Chater, Matthew Wilcox, Iain Brownlee,
Michael I. Trenell, Chris Seal, Jeffrey Pearson, The United Kingdom
AN IMBALANCE BETWEEN TH17 AND TREG KEY TO
PATHOGENESIS OF NON-ALCOHOLIC FATTY LIVER
DISEASE IN MORBIDLY OBESE PATIENTS
Paula Iruzubieta, Maria Teresa Arias-Loste*, Agustín Domínguez,
Antonio López-Useros, Carolina Santa Cruz, Ángel Estébanez,
David San Segundo, David Ramos, Ainara Azueta, Susana Llerena,
Carmen Alonso, Joaquin Cabezas, Marcos López Hoyos, Javier Crespo,
Spain
PREVALENCE OF PATATIN-LIKE PHOSPHOLIPASE DOMAIN
CONTAINING 3 (PNPLA3) RS738409 C/G POLYMORPHISM IN
PATIENTS WITH BONA-FIDE POST-NASH CIRRHOSIS
Paolo Gallo, Umberto Vespasiani Gentilucci, Giovanni Galati,
Antonio De Vincentis*, Livia Piccioni, Elisabetta Riva, Antonio Picardi,
Italy
LIVER ENZYMES, ADIPONECTIN AND VITAMIN D LEVELS
AS PREDICTORS OF DIABETES – DATA FROM THE HEINZ
NIXDORF RECALL STUDY
Julia Kälsch*, Lars P. Bechmann, Dominik Heider, Paul Manka,
Hagen Kälsch, Jan-Peter Sowa, Susanne Moebus, Uta Slomiany,
Karl-Heinz Jöckel, Raimund Erbel, Guido Gerken, Ali Canbay, Germany
THE MACROPHAGE ACTIVATION MARKER SOLUBLE
CD163 IS INDEPENDENTLY ASSOCIATED WITH THE
SEVERITY OF NAFLD IN MORBID OBESITY AND REDUCED
BY BARIATRIC SURGERY
Konstantin Kazankov*, Joan Tordjman, Holger J. Møller,
Hendrik Vilstrup, Christine Poitou, Pierre Bedossa, Jean-Luc Bouillot,
Karine Clement, Henning Grønbæk, Denmark
Vienna, Austria • April 22–26, 2015 303
